Other Vaccines - Croatia

  • Croatia
  • The revenue in the Other Vaccines market in Croatia is projected to reach US$18.11m by 2024.
  • It is expected to show an annual growth rate of 9.99% from 2024 to 2029, resulting in a market volume of US$29.15m by 2029.
  • In global comparison, United States is projected to generate the highest revenue of US$24,730.00m in 2024.
  • Croatia is experiencing a growing demand for other vaccines, driven by an increasing awareness of the importance of preventive healthcare among its population.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other Vaccines market in Croatia has shown significant growth in recent years.

Customer preferences:
The demand for other vaccines in Croatia has increased due to the growing awareness of the importance of vaccination and the government's efforts to promote vaccination. Additionally, the rise in tourism in Croatia has also contributed to the growth of the market, as tourists are often required to be vaccinated against certain diseases before entering the country.

Trends in the market:
One of the major trends in the Other Vaccines market in Croatia is the increasing demand for travel vaccines. As more people travel to Croatia, the demand for travel vaccines has increased, especially for diseases such as hepatitis A and B, typhoid fever, and rabies. Another trend is the growing popularity of the human papillomavirus (HPV) vaccine among young adults. The vaccine is recommended for both males and females between the ages of 9 and 26, and its popularity has been increasing in recent years.

Local special circumstances:
Croatia has a well-developed healthcare system, which has contributed to the growth of the Other Vaccines market. The country has a universal healthcare system, and vaccines are provided free of charge to all citizens. Additionally, the government has implemented a number of programs to promote vaccination, including the National Immunization Program, which provides free vaccines to children and adults.

Underlying macroeconomic factors:
The growth of the Other Vaccines market in Croatia can be attributed to several macroeconomic factors. The country's economy has been growing steadily in recent years, which has led to an increase in healthcare spending. Additionally, the government's efforts to promote vaccination have also contributed to the growth of the market. The rise in tourism in Croatia has also played a role, as tourists are often required to be vaccinated against certain diseases before entering the country. Overall, the Other Vaccines market in Croatia is expected to continue to grow in the coming years, driven by increasing demand for travel vaccines and the growing popularity of the HPV vaccine.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)